ATE135007T1 - N-(pyrrolo(2-3-d)pyrimidin-3-ylacyl)- glutaminsäurederivate - Google Patents

N-(pyrrolo(2-3-d)pyrimidin-3-ylacyl)- glutaminsäurederivate

Info

Publication number
ATE135007T1
ATE135007T1 AT90123671T AT90123671T ATE135007T1 AT E135007 T1 ATE135007 T1 AT E135007T1 AT 90123671 T AT90123671 T AT 90123671T AT 90123671 T AT90123671 T AT 90123671T AT E135007 T1 ATE135007 T1 AT E135007T1
Authority
AT
Austria
Prior art keywords
ylacyl
pyrrolo
pyrimidine
acid derivatives
glutamine acid
Prior art date
Application number
AT90123671T
Other languages
English (en)
Inventor
Edward C Taylor
Dietmar G Kuhnt
Chuan Shih
Gerald B Grindey
Original Assignee
Univ Princeton
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27503964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE135007(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/528,805 external-priority patent/US4996206A/en
Application filed by Univ Princeton, Lilly Co Eli filed Critical Univ Princeton
Application granted granted Critical
Publication of ATE135007T1 publication Critical patent/ATE135007T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT90123671T 1989-12-11 1990-12-10 N-(pyrrolo(2-3-d)pyrimidin-3-ylacyl)- glutaminsäurederivate ATE135007T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US44874289A 1989-12-11 1989-12-11
US47965590A 1990-02-08 1990-02-08
US07/528,805 US4996206A (en) 1989-12-11 1990-05-24 N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
US07/528,155 US5028608A (en) 1989-12-11 1990-05-24 N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives

Publications (1)

Publication Number Publication Date
ATE135007T1 true ATE135007T1 (de) 1996-03-15

Family

ID=27503964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90123671T ATE135007T1 (de) 1989-12-11 1990-12-10 N-(pyrrolo(2-3-d)pyrimidin-3-ylacyl)- glutaminsäurederivate

Country Status (22)

Country Link
EP (1) EP0432677B1 (de)
JP (1) JP3016876B2 (de)
CN (1) CN1030608C (de)
AR (1) AR245129A1 (de)
AT (1) ATE135007T1 (de)
AU (1) AU640182B2 (de)
CA (1) CA2031890C (de)
CY (1) CY2076B1 (de)
DE (2) DE69025723T2 (de)
DK (1) DK0432677T3 (de)
ES (1) ES2084639T4 (de)
GR (1) GR3019784T3 (de)
HK (1) HK1000920A1 (de)
HU (1) HU218483B (de)
IE (1) IE904445A1 (de)
IL (1) IL96531A (de)
LU (1) LU91147I2 (de)
NL (1) NL300181I2 (de)
NZ (1) NZ236385A (de)
PT (1) PT96140B (de)
RU (1) RU2057131C9 (de)
SG (1) SG48098A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254687A (en) 1991-12-04 1993-10-19 The Trustees Of Princeton University Process for the preparation of pyrrolo[2,3-d]pyrimidines
US5235053A (en) * 1992-06-22 1993-08-10 Eli Lilly And Company Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates
EP2316468A1 (de) 2002-02-22 2011-05-04 Shire LLC Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Dextroamphetamin
CN100344615C (zh) * 2004-11-25 2007-10-24 重庆医药工业研究院有限责任公司 制备N－(吡咯并[2,3－d]嘧啶－5－基)酰基谷氨酸衍生物的方法及中间体
CN101146532B (zh) 2005-01-21 2012-05-09 阿斯泰克斯治疗有限公司 药物化合物
EP2270012A1 (de) 2006-08-14 2011-01-05 Sicor, Inc. Kristalline Formen von Pemetrexed-Disäure und Herstellungsverfahren dafür
US7994180B2 (en) 2006-08-14 2011-08-09 Sicor Inc. Processes for preparing intermediates of pemetrexed
JP2008543975A (ja) 2006-08-14 2008-12-04 シコール インコーポレイティド 高度に純粋なペメトレキセド二酸およびその調製方法
KR101083230B1 (ko) 2006-08-14 2011-11-11 시코르, 인크. 페메트렉세드 이산의 동결 건조된 약학적 허용염의 제조 방법
EP2073807A1 (de) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmazeutische kombinationen
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
CN101417998B (zh) 2007-10-24 2012-10-24 重庆医药工业研究院有限责任公司 一种培美曲塞盐的纯化方法
ME02273B (me) * 2008-06-06 2016-02-20 Boehringer Ingelheim Int Farmaceutska kombinacija
AU2015210337B2 (en) * 2008-06-06 2017-02-02 Boehringer Ingelheim International Gmbh Pharmaceutical combination
CN101684121B (zh) * 2008-09-22 2013-04-03 重庆医药工业研究院有限责任公司 培美曲塞二酸的新晶型及其制备方法
EP2504341A1 (de) 2009-11-24 2012-10-03 Azad Pharmaceutical Ingredients AG Neue kristalline form von pemetrexed-dinatrium
EP3210629A1 (de) 2012-05-30 2017-08-30 Fresenius Kabi Oncology Ltd Pharmazeutische zusammensetzungen aus pemetrexed
ITRM20120398A1 (it) 2012-08-08 2014-02-09 Berlin Chemie Ag Procedimento di sintesi pemetrexed e suo sale di lisina.
US20160051679A1 (en) 2013-04-12 2016-02-25 Actavis Group Ptc Ehf. Pemetrexed Formulation
WO2014185797A1 (en) 2013-05-17 2014-11-20 Instytut Farmaceutyczny Process for the preparation of high purity amorphous pemetrexed disodium and crystalline forms of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3- d] pyrimidin-5-yl)ethyl] benzoyl]-l-glutamic acid
US20160145260A1 (en) 2013-06-14 2016-05-26 Synthon B.V. Stable pemetrexed arginine salt and compositions comprising it
EP3021849B1 (de) * 2013-07-16 2019-10-09 Dr. Reddy's Laboratories Ltd. Neuartige kristalline formen von pemetrexed-tromethamin-salzen
NZ630292A (en) 2013-11-25 2015-02-27 Shilpa Medicare Ltd Process for crystalline pemetrexed dipotassium salt
PT3206666T (pt) 2014-10-16 2020-03-11 Synthon Bv Composição farmacêutica líquida compreendendo pemetrexedo
CN104672241B (zh) * 2015-01-29 2018-04-24 王磊 吡咯并[2,3-d]嘧啶类化合物及其用途
FR3037956B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES3057783T3 (en) 2016-03-15 2026-03-04 Oryzon Genomics Sa Combinations of lsd1 inhibitors for use in the treatment of neoplastic diseases
EP3675864A4 (de) * 2017-08-31 2022-02-16 Duquesne University of The Holy Spirit Erste vertreter von shmt2- und mthfd2-inhibitoren als antitumormittel
CN110305137A (zh) * 2018-03-20 2019-10-08 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法
CN110305134B (zh) * 2018-03-20 2022-02-22 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法
CN110305136A (zh) * 2018-03-20 2019-10-08 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法
CN110305135B (zh) * 2018-03-20 2022-02-22 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
DK172753B1 (da) * 1988-05-25 1999-06-28 Lilly Co Eli N-(5,6,7,8-tetrahydropyrido[2,3--d]pyrimidin-6-yl-alkanoyl)-glutaminsyrederivater, deres anvendelse, farmaceutiske præparat
US4883799A (en) * 1988-06-29 1989-11-28 The Trustees Of Princeton University N-(4-(1-hydroxy-3-(5,6,7,8-tetrahydropyrido(2,3,-d)-pyrimidin-6-yl)prop-2-yl)benzoyl)glutamic acid derivatives

Also Published As

Publication number Publication date
AU6779190A (en) 1991-06-13
HUT58335A (en) 1992-02-28
NZ236385A (en) 1992-05-26
SG48098A1 (en) 1998-04-17
NL300181I1 (nl) 2005-05-02
IL96531A (en) 1995-08-31
DE122005000012I2 (de) 2006-02-09
HK1000920A1 (en) 1998-05-08
CA2031890C (en) 2000-07-25
AU640182B2 (en) 1993-08-19
HU908147D0 (en) 1991-06-28
RU2057131C9 (ru) 2006-04-10
DE69025723D1 (de) 1996-04-11
CA2031890A1 (en) 1991-06-12
PT96140B (pt) 1997-06-30
IE904445A1 (en) 1991-06-19
DE69025723T2 (de) 1996-10-31
ES2084639T4 (es) 2013-06-11
EP0432677B1 (de) 1996-03-06
NL300181I2 (nl) 2005-06-01
AR245129A1 (es) 1993-12-30
HU218483B (hu) 2000-09-28
LU91147I2 (fr) 2005-05-17
DE122005000012I1 (de) 2005-06-23
CN1055182A (zh) 1991-10-09
IL96531A0 (en) 1991-09-16
JP3016876B2 (ja) 2000-03-06
DK0432677T3 (da) 1996-04-09
RU2057131C1 (ru) 1996-03-27
ES2084639T3 (es) 1996-05-16
CN1030608C (zh) 1996-01-03
JPH083166A (ja) 1996-01-09
PT96140A (pt) 1991-09-30
CY2076B1 (en) 1998-09-11
EP0432677A1 (de) 1991-06-19
GR3019784T3 (en) 1996-07-31

Similar Documents

Publication Publication Date Title
ATE135007T1 (de) N-(pyrrolo(2-3-d)pyrimidin-3-ylacyl)- glutaminsäurederivate
FI901490A7 (fi) Aminohappojohdannaiset
DK340088A (da) Aminosyrederivater
DK295288A (da) (1h-azol-1-ylmethyl)substituerede benzotriazolderivater
TR26815A (tr) Azolilmetil-sikropil türevleri
FI904360A7 (fi) Aminohappojohdannaiset
FI901129A7 (fi) Aminohappojohdannaisia
FI895718A7 (fi) -amino-boronihappo-johdannaiset
DK686487D0 (da) 1h-imidazol-5-carboxylsyrederivater
DK101287A (da) 1h-imidazol-5-carboxylsyrederivater
DK507188A (da) Cholecalciferolderivater
DK633588A (da) Aminderivater
DK523288A (da) Aminosyrederivater
DK378088D0 (da) Alkenderivater
FI901730A7 (fi) Aminohappojohdannaisia
DK49688D0 (da) Propiolophenonderivater
DK655487D0 (da) Furanuronsyrederivater
ATE163641T1 (de) Carbamoylderivate
FI902321A7 (fi) Buteenihappojohdannaiset
FI906104A7 (fi) Naftyylisulfonyylialkaanihappojohdannaisia
DK271088D0 (da) Tienopyridinderivater
BR9003294A (pt) Micropulverizador
DE69031181D1 (de) Perylenequinon (UCN-1028D) Derivate
FI893041A7 (fi) Substituoidut atsasykloheksyylijohdannaiset
DK695788A (da) Naphtalenderivater